Your browser doesn't support javascript.
loading
Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk.
Vachon, Celine M; Scott, Christopher G; Tamimi, Rulla M; Thompson, Deborah J; Fasching, Peter A; Stone, Jennifer; Southey, Melissa C; Winham, Stacey; Lindström, Sara; Lilyquist, Jenna; Giles, Graham G; Milne, Roger L; MacInnis, Robert J; Baglietto, Laura; Li, Jingmei; Czene, Kamila; Bolla, Manjeet K; Wang, Qin; Dennis, Joe; Haeberle, Lothar; Eriksson, Mikael; Kraft, Peter; Luben, Robert; Wareham, Nick; Olson, Janet E; Norman, Aaron; Polley, Eric C; Maskarinec, Gertraud; Le Marchand, Loic; Haiman, Christopher A; Hopper, John L; Couch, Fergus J; Easton, Douglas F; Hall, Per; Chatterjee, Nilanjan; Garcia-Closas, Montse.
Afiliação
  • Vachon CM; Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, 55905, MN, USA. vachon.celine@mayo.edu.
  • Scott CG; Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, 55905, MN, USA.
  • Tamimi RM; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, 02115, MA, USA.
  • Thompson DJ; Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, MA, 02115, USA.
  • Fasching PA; Program in Genetic Epidemiology and Statistical Genetics, Harvard TH Chan School of Public Health, Boston, MA, 02115, USA.
  • Stone J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK.
  • Southey MC; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen Nuremberg, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, 91054, Erlangen, Germany.
  • Winham S; Department of Medicine, Division of Hematology and Oncology, University of California at Los Angeles, David Geffen School of Medicine, Los Angeles, CA, 90095, USA.
  • Lindström S; The Curtin UWA Centre for Genetic Origins of Health and Disease, Curtin University and University of Western Australia, Perth, Western Australia, 6009, Australia.
  • Lilyquist J; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, 3010, Australia.
  • Giles GG; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, 3168, Australia.
  • Milne RL; Department of Clinical Pathology, The University of Melbourne, Melbourne, Victoria, 3010, Australia.
  • MacInnis RJ; Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, 55905, MN, USA.
  • Baglietto L; Department of Epidemiology, University of Washington School of Public Health, Seattle, WA, 98195, USA.
  • Li J; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA.
  • Czene K; Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, 55905, MN, USA.
  • Bolla MK; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, 3010, Australia.
  • Wang Q; Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Victoria, 3004, Australia.
  • Dennis J; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
  • Haeberle L; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, 3010, Australia.
  • Eriksson M; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, 3168, Australia.
  • Kraft P; Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Victoria, 3004, Australia.
  • Luben R; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, 3010, Australia.
  • Wareham N; Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Victoria, 3004, Australia.
  • Olson JE; Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Victoria, 3004, Australia.
  • Norman A; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Polley EC; Human Genetics, Genome Institute of Singapore, Singapore, Singapore.
  • Maskarinec G; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 65, Stockholm, Sweden.
  • Le Marchand L; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK.
  • Haiman CA; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK.
  • Hopper JL; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK.
  • Couch FJ; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen Nuremberg, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, 91054, Erlangen, Germany.
  • Easton DF; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 65, Stockholm, Sweden.
  • Hall P; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, 02115, MA, USA.
  • Chatterjee N; Program in Genetic Epidemiology and Statistical Genetics, Harvard TH Chan School of Public Health, Boston, MA, 02115, USA.
  • Garcia-Closas M; Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK.
Breast Cancer Res ; 21(1): 68, 2019 05 22.
Article em En | MEDLINE | ID: mdl-31118087
ABSTRACT

BACKGROUND:

Mammographic breast density, adjusted for age and body mass index, and a polygenic risk score (PRS), comprised of common genetic variation, are both strong risk factors for breast cancer and increase discrimination of risk models. Understanding their joint contribution will be important to more accurately predict risk.

METHODS:

Using 3628 breast cancer cases and 5126 controls of European ancestry from eight case-control studies, we evaluated joint associations of a 77-single nucleotide polymorphism (SNP) PRS and quantitative mammographic density measures with breast cancer. Mammographic percent density and absolute dense area were evaluated using thresholding software and examined as residuals after adjusting for age, 1/BMI, and study. PRS and adjusted density phenotypes were modeled both continuously (per 1 standard deviation, SD) and categorically. We fit logistic regression models and tested the null hypothesis of multiplicative joint associations for PRS and adjusted density measures using likelihood ratio and global and tail-based goodness of fit tests within the subset of six cohort or population-based studies.

RESULTS:

Adjusted percent density (odds ratio (OR) = 1.45 per SD, 95% CI 1.38-1.52), adjusted absolute dense area (OR = 1.34 per SD, 95% CI 1.28-1.41), and the 77-SNP PRS (OR = 1.52 per SD, 95% CI 1.45-1.59) were associated with breast cancer risk. There was no evidence of interaction of the PRS with adjusted percent density or dense area on risk of breast cancer by either the likelihood ratio (P > 0.21) or goodness of fit tests (P > 0.09), whether assessed continuously or categorically. The joint association (OR) was 2.60 in the highest categories of adjusted PD and PRS and 0.34 in the lowest categories, relative to women in the second density quartile and middle PRS quintile.

CONCLUSIONS:

The combined associations of the 77-SNP PRS and adjusted density measures are generally well described by multiplicative models, and both risk factors provide independent information on breast cancer risk.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Biomarcadores Tumorais / Herança Multifatorial / Densidade da Mama Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Biomarcadores Tumorais / Herança Multifatorial / Densidade da Mama Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article